Discover how hemophilia A affects blood clotting, its genetic patterns, warning signs, advanced treatment options, and ...

The UNC technology, developed by Pediatrics Professor Chengwen Li, M.D., Ph.D., uses adeno-associated viruses (AAVs) to ferry ...

A single-center U.S. study found relatively little genetic testing is being done for girls with a 50% risk of being a carrier ...

A new promo for Roche’s blockbuster hemophilia A drug Hemlibra focuses less on those with the genetic bleeding disorder and ...

Hemophilia disease is a rare inherited bleeding disorder. People with this genetic condition do not produce sufficient clotting factors, which can cause uncontrolled external or internal bleeding.

Hemophilia C is found in every 100,000 people in the general population. The reason for this is that Factor 11 lacks an autosomal recessive genetic pattern, which means that there will be a gene ...

China recently approved its first gene therapy for the rare genetic disorder hemophilia B, drawing renewed attention to this often-overlooked condition. Hemophilia is a rare but serious inherited ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

In the spring of 2024, the US Food and Drug Administration (FDA) approved fidanacogene elaparvovec (Beqvez), only the second gene therapy product for hemophilia B. Just a few months later ...